Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
5.60
-0.21 (-3.61%)
At close: Mar 9, 2026, 4:00 PM EDT
5.64
+0.04 (0.71%)
After-hours: Mar 9, 2026, 7:59 PM EDT
Xeris Biopharma Holdings Employees
Xeris Biopharma Holdings had 394 employees as of December 31, 2024. The number of employees increased by 17 or 4.51% compared to the previous year.
Employees
394
Change (1Y)
17
Growth (1Y)
4.51%
Revenue / Employee
$740,723
Profits / Employee
$1,406
Market Cap
965.62M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| AbCellera Biologics | 596 |
| Pharming Group | 404 |
| UroGen Pharma | 287 |
| Geron | 229 |
| Inhibrx Biosciences | 161 |
| Cullinan Therapeutics | 111 |
| ArriVent BioPharma | 52 |
| GH Research | 50 |
XERS News
- 7 days ago - Xeris Biopharma Holdings, Inc. (XERS) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Xeris Biopharma Reports Record Performance for Fourth Quarter and Full Year 2025 and Provides Full Year 2026 Guidance - Business Wire
- 10 days ago - Why Are Shares Of Xeris Biopharma Falling Friday? - Benzinga
- 11 days ago - Xeris Biopharma Subsidiaries File Recorlev® Patent Infringement Lawsuit - Business Wire
- 20 days ago - Xeris Biopharma to Report Full Year 2025 Financial Results and Provide Full Year 2026 Guidance on March 2, 2026 - Business Wire
- 4 weeks ago - Xeris Biopharma: Strong Recorlev Momentum And Pipeline Opportunity - Seeking Alpha
- 2 months ago - Xeris Expects to Deliver Record Fourth Quarter and Full-Year 2025 Total Revenue - Business Wire
- 2 months ago - Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire